• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2023 Results

    2/20/24 6:30:00 AM ET
    $WLKP
    Major Chemicals
    Industrials
    Get the next $WLKP alert in real time by email
    • Declared quarterly distribution of $0.4714 per unit; 38th consecutive quarterly distribution

    Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2023 of $14.3 million, or $0.41 per limited partner unit, a decrease of $2.5 million compared to fourth quarter 2022 net income of $16.8 million. The decrease in net income in the fourth quarter of 2023 when compared to the prior-year period was largely driven by higher interest expense. Cash flows from operating activities in the fourth quarter of 2023 were $107.7 million, a decrease of $14.9 million compared to fourth quarter 2022 cash flows from operating activities of $122.6 million, due to lower net income and less favorable working capital changes. For the three months ended December 31, 2023, MLP distributable cash flow was $16.4 million, a decrease of $3.9 million compared to fourth quarter 2022 MLP distributable cash flow of $20.3 million. The decrease in MLP distributable cash flow and associated trailing twelve-month coverage ratio was primarily due to lower net income and higher maintenance capital expenditures.

    Fourth quarter 2023 net income attributable to the Partnership of $14.3 million increased by $1.1 million compared to third quarter 2023 net income of $13.2 million, primarily due to higher production and sales volume. Fourth quarter 2023 cash flows from operating activities of $107.7 million increased by $6.8 million compared to third quarter 2023 cash flows from operating activities of $100.9 million due to higher net income. Fourth quarter 2023 MLP distributable cash flow of $16.4 million increased by $2.8 million compared to third quarter 2023 MLP distributable cash flow of $13.6 million, primarily due to lower maintenance capital expenditures.

    For the full year 2023, net income attributable to the Partnership of $54.3 million, or $1.54 per limited partner unit, decreased by $9.9 million compared to full year of 2022 net income attributable to the Partnership of $64.2 million. The decrease in net income attributable to the Partnership was primarily due to higher interest expense. Cash flows from operating activities for the full year of 2023 were $452.0 million, a decrease of $11.7 million compared to the full year of 2022 cash flows from operating activities of $463.7 million. This decrease in cash flows from operating activities was primarily due to higher interest expense and cash expenditures for the Calvert City, Kentucky, turnaround. For the year ended December 31, 2023, MLP distributable cash flow was $62.6 million, a decrease of $13.3 million compared to MLP distributable cash flow of $75.9 million for the year ended December 31, 2022.

    "The Partnership performed well in 2023 as we successfully completed the maintenance turnaround at our Calvert City ethylene unit in May on schedule. We also maximized the margin on third-party ethylene volumes in 2023 by opportunistically timing our third-party sales," said Albert Chao, President and Chief Executive Officer. "We plan to perform a maintenance turnaround at our Petro 1 ethylene unit in the second half of 2024. Combined with our outlook for continued low third-party ethylene margins and elevated interest rates, the lost production during the Petro 1 turnaround may cause our coverage ratio to dip below 1.00x in 2024. However, after the turnarounds at Petro 2 in 2021, Calvert City in 2023 and Petro 1 in 2024, we should be positioned to run at full capacity, with a corresponding benefit to our coverage ratio in the following years."

    On January 22, 2024, the Partnership announced that the Board of Directors of Westlake Chemical Partners GP LLC had approved a quarterly distribution for the fourth quarter of 2023 of $0.4714 per unit to be payable on February 20, 2024 to unitholders of record as of February 2, 2024, representing the 38th consecutive quarterly distribution to our unitholders. MLP distributable cash flow provided trailing twelve-month coverage of 0.94x the declared distributions for the fourth quarter of 2023, which was a decrease from the trailing twelve-month coverage ratio of 1.00x at the end of the third quarter of 2023.

    OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.

    The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to the results of our turnaround activities, including the Petro 1 turnaround, our future coverage ratio, our outlook for third-party ethylene margins, our expectations regarding future interest rates, the ability to deliver value, returns, predictable cash flows and distributions to unitholders, the expectation that strong distributions will continue, and the nature of the sales agreement with Westlake, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, pandemic infectious diseases and the response thereto; operating difficulties; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions and commitments of Westlake Corporation; actions of third parties; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC in March 2023, and Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, which was filed with the SEC in November 2023.

    This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

    Use of Non-GAAP Financial Measures

    This release makes reference to certain "non-GAAP" financial measures, such as MLP distributable cash flow and EBITDA. For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") in the statement of income, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. We report our financial results in accordance with U.S. GAAP, but believe that certain non-GAAP financial measures, such as MLP distributable cash flow and EBITDA, provide useful supplemental information to investors regarding the underlying business trends and performance of our ongoing operations and are useful for period-over-period comparisons of such operations. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with U.S. GAAP. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake Corporation's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. Reconciliations of MLP distributable cash flow to net income and to net cash provided by operating activities and of EBITDA to net income, income from operations and net cash provided by operating activities can be found in the financial schedules at the end of this press release.

    Westlake Chemical Partners LP

    Westlake Chemical Partners is a limited partnership formed by Westlake Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns a 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana, and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.

    Westlake Chemical Partners LP Conference Call Information:

    A conference call to discuss Westlake Chemical Partners' fourth quarter and full year 2023 results will be held Tuesday, February 20th, 2024 at 1:00 PM Eastern Time (12:00 PM Central Time). To access the conference call, please register at: https://register.vevent.com/register/BI4edd1a6cc9e749b585fb66878269ae6f. A dial-in will be provided upon registration.

    The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/gwkvbr9r and the earnings release can be obtained via the Partnership web page at: https://investors.wlkpartners.com/corporate-profile/default.aspx.

    WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")

     

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

     

     

     

    Three Months Ended December 31,

     

    Twelve Months Ended December 31,

     

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

     

     

    (In thousands of dollars, except per unit data)

    Revenue

     

     

     

     

     

     

     

     

    Net sales—Westlake Corporation ("Westlake")

     

    $

    255,306

     

     

    $

    322,868

     

     

    $

    1,026,655

     

     

    $

    1,342,910

     

    Net co-products, ethylene and other sales—third parties

     

     

    41,967

     

     

     

    43,971

     

     

     

    164,136

     

     

     

    250,237

     

    Total net sales

     

     

    297,273

     

     

     

    366,839

     

     

     

    1,190,791

     

     

     

    1,593,147

     

    Cost of sales

     

     

    196,590

     

     

     

    268,709

     

     

     

    803,332

     

     

     

    1,215,782

     

    Gross profit

     

     

    100,683

     

     

     

    98,130

     

     

     

    387,459

     

     

     

    377,365

     

    Selling, general and administrative expenses

     

     

    7,867

     

     

     

    2,854

     

     

     

    29,751

     

     

     

    29,678

     

    Income from operations

     

     

    92,816

     

     

     

    95,276

     

     

     

    357,708

     

     

     

    347,687

     

    Other income (expense)

     

     

     

     

     

     

     

     

    Interest expense—Westlake

     

     

    (6,632

    )

     

     

    (4,704

    )

     

     

    (26,501

    )

     

     

    (13,407

    )

    Other income, net

     

     

    1,079

     

     

     

    883

     

     

     

    4,232

     

     

     

    1,566

     

    Income before income taxes

     

     

    87,263

     

     

     

    91,455

     

     

     

    335,439

     

     

     

    335,846

     

    Provision for income taxes

     

     

    206

     

     

     

    195

     

     

     

    813

     

     

     

    1,017

     

    Net income

     

     

    87,057

     

     

     

    91,260

     

     

     

    334,626

     

     

     

    334,829

     

    Less: Net income attributable to noncontrolling interest in Westlake Chemical OpCo LP ("OpCo")

     

     

    72,758

     

     

     

    74,476

     

     

     

    280,343

     

     

     

    270,656

     

    Net income attributable to Westlake Partners

     

    $

    14,299

     

     

    $

    16,784

     

     

    $

    54,283

     

     

    $

    64,173

     

     

     

     

     

     

     

     

     

     

    Net income per limited partner unit attributable to Westlake Partners (basic and diluted)

     

     

     

     

     

     

     

     

    Common units

     

    $

    0.41

     

     

    $

    0.48

     

     

    $

    1.54

     

     

    $

    1.82

     

     

     

     

     

     

     

     

     

     

    Distributions declared per unit

     

    $

    0.4714

     

     

    $

    0.4714

     

     

    $

    1.8856

     

     

    $

    1.8856

     

     

     

     

     

     

     

     

     

     

    MLP distributable cash flow

     

    $

    16,418

     

     

    $

    20,261

     

     

    $

    62,574

     

     

    $

    75,870

     

     

     

     

     

     

     

     

     

     

    Distributions declared

     

     

     

     

     

     

     

     

    Limited partner units—publicly and privately held

     

    $

    9,949

     

     

    $

    9,947

     

     

    $

    39,790

     

     

    $

    39,775

     

    Limited partner units—Westlake

     

     

    6,658

     

     

     

    6,657

     

     

     

    26,631

     

     

     

    26,628

     

    Total distributions declared

     

    $

    16,607

     

     

    $

    16,604

     

     

    $

    66,421

     

     

    $

    66,403

     

    EBITDA

     

    $

    122,196

     

     

    $

    125,551

     

     

    $

    472,143

     

     

    $

    470,327

     

    WESTLAKE CHEMICAL PARTNERS LP

     

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Unaudited)

     

     

     

    December 31,

     

     

     

    2023

     

     

     

    2022

     

     

     

    (In thousands of dollars)

    ASSETS

     

     

     

     

    Current assets

     

     

     

     

    Cash and cash equivalents

     

    $

    58,619

     

     

    $

    64,782

     

    Receivable under the Investment Management Agreement—Westlake

     

     

    94,444

     

     

     

    64,996

     

    Accounts receivable, net—Westlake

     

     

    49,565

     

     

     

    90,965

     

    Accounts receivable, net—third parties

     

     

    18,701

     

     

     

    20,030

     

    Inventories

     

     

    4,432

     

     

     

    4,715

     

    Prepaid expenses and other current assets

     

     

    442

     

     

     

    305

     

    Total current assets

     

     

    226,203

     

     

     

    245,793

     

    Property, plant and equipment, net

     

     

    943,843

     

     

     

    990,213

     

    Other assets, net

     

     

    146,796

     

     

     

    135,973

     

    Total assets

     

    $

    1,316,842

     

     

    $

    1,371,979

     

     

     

     

     

     

    LIABILITIES AND EQUITY

     

     

     

     

    Current liabilities (accounts payable and accrued and other liabilities)

     

    $

    56,335

     

     

    $

    66,941

     

    Long-term debt payable to Westlake

     

     

    399,674

     

     

     

    399,674

     

    Other liabilities

     

     

    4,583

     

     

     

    1,656

     

    Total liabilities

     

     

    460,592

     

     

     

    468,271

     

    Common unitholders—publicly and privately held

     

     

    473,513

     

     

     

    480,643

     

    Common unitholder—Westlake

     

     

    48,993

     

     

     

    53,859

     

    General partner—Westlake

     

     

    (242,572

    )

     

     

    (242,572

    )

    Total Westlake Partners partners' capital

     

     

    279,934

     

     

     

    291,930

     

    Noncontrolling interest in OpCo

     

     

    576,316

     

     

     

    611,778

     

    Total equity

     

     

    856,250

     

     

     

    903,708

     

    Total liabilities and equity

     

    $

    1,316,842

     

     

    $

    1,371,979

     

    WESTLAKE CHEMICAL PARTNERS LP

     

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (Unaudited)

     

     

     

    Twelve Months Ended December 31,

     

     

     

    2023

     

     

     

    2022

     

     

     

    (In thousands of dollars)

    Cash flows from operating activities

     

     

     

     

    Net income

     

    $

    334,626

     

     

    $

    334,829

     

    Adjustments to reconcile net income to net cash provided by operating activities

     

     

     

     

    Depreciation and amortization

     

     

    110,203

     

     

     

    121,074

     

    Net loss on disposition and other

     

     

    4,906

     

     

     

    5,063

     

    Other balance sheet changes

     

     

    2,264

     

     

     

    2,770

     

    Net cash provided by operating activities

     

     

    451,999

     

     

     

    463,736

     

    Cash flows from investing activities

     

     

     

     

    Additions to property, plant and equipment

     

     

    (46,821

    )

     

     

    (54,118

    )

    Investments with Westlake under the Investment Management Agreement

     

     

    (174,116

    )

     

     

    (319,884

    )

    Maturities of investments with Westlake under the Investment Management Agreement

     

     

    145,000

     

     

     

    362,000

     

    Net cash used for investing activities

     

     

    (75,937

    )

     

     

    (12,002

    )

    Cash flows from financing activities

     

     

     

     

    Proceeds from debt payable to Westlake

     

     

    209,250

     

     

     

    32,000

     

    Repayment of debt payable to Westlake

     

     

    (209,250

    )

     

     

    (32,000

    )

    Distributions to noncontrolling interest retained in OpCo by Westlake

     

     

    (315,805

    )

     

     

    (337,598

    )

    Distributions to unitholders

     

     

    (66,420

    )

     

     

    (66,411

    )

    Net cash used for financing activities

     

     

    (382,225

    )

     

     

    (404,009

    )

    Net increase (decrease) in cash and cash equivalents

     

     

    (6,163

    )

     

     

    47,725

     

    Cash and cash equivalents at beginning of the year

     

     

    64,782

     

     

     

    17,057

     

    Cash and cash equivalents at end of the year

     

    $

    58,619

     

     

    $

    64,782

     

    WESTLAKE CHEMICAL PARTNERS LP

     

    RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME

    AND NET CASH PROVIDED BY OPERATING ACTIVITIES

    (Unaudited)

     

     

     

    Three Months

    Ended

    September 30,

     

    Three Months Ended December 31,

     

    Twelve Months Ended December 31,

     

     

     

    2023

     

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

     

     

    (In thousands of dollars)

    Net cash provided by operating activities

     

    $

    100,925

     

     

    $

    107,671

     

     

    $

    122,574

     

     

    $

    451,999

     

     

    $

    463,736

     

    Changes in operating assets and liabilities and other

     

     

    (20,072

    )

     

     

    (20,614

    )

     

     

    (31,314

    )

     

     

    (117,373

    )

     

     

    (128,907

    )

    Net income

     

     

    80,853

     

     

     

    87,057

     

     

     

    91,260

     

     

     

    334,626

     

     

     

    334,829

     

    Add:

     

     

     

     

     

     

     

     

     

     

    Depreciation, amortization and disposition of property, plant and equipment

     

     

    32,242

     

     

     

    28,796

     

     

     

    29,711

     

     

     

    115,136

     

     

     

    125,781

     

    Less:

     

     

     

     

     

     

     

     

     

     

    Contribution to turnaround reserves

     

     

    (7,565

    )

     

     

    (7,682

    )

     

     

    (7,364

    )

     

     

    (29,520

    )

     

     

    (29,175

    )

    Maintenance capital expenditures

     

     

    (22,862

    )

     

     

    (11,805

    )

     

     

    (7,077

    )

     

     

    (49,212

    )

     

     

    (45,249

    )

    Distributable cash flow attributable to noncontrolling interest in OpCo

     

     

    (69,048

    )

     

     

    (79,948

    )

     

     

    (86,269

    )

     

     

    (308,456

    )

     

     

    (310,316

    )

    MLP distributable cash flow

     

    $

    13,620

     

     

    $

    16,418

     

     

    $

    20,261

     

     

    $

    62,574

     

     

    $

    75,870

     

    WESTLAKE CHEMICAL PARTNERS LP

     

    RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND

    NET CASH PROVIDED BY OPERATING ACTIVITIES

    (Unaudited)

     

     

     

    Three Months

    Ended

    September 30,

     

    Three Months Ended December 31,

     

    Twelve Months Ended December 31,

     

     

     

    2023

     

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

     

     

    (In thousands of dollars)

    Net cash provided by operating activities

     

    $

    100,925

     

     

    $

    107,671

     

     

    $

    122,574

     

     

    $

    451,999

     

     

    $

    463,736

     

    Changes in operating assets and liabilities and other

     

     

    (20,072

    )

     

     

    (20,614

    )

     

     

    (31,314

    )

     

     

    (117,373

    )

     

     

    (128,907

    )

    Net income

     

     

    80,853

     

     

     

    87,057

     

     

     

    91,260

     

     

     

    334,626

     

     

     

    334,829

     

    Less:

     

     

     

     

     

     

     

     

     

     

    Other income, net

     

     

    1,272

     

     

     

    1,079

     

     

     

    883

     

     

     

    4,232

     

     

     

    1,566

     

    Interest expense—Westlake

     

     

    (6,437

    )

     

     

    (6,632

    )

     

     

    (4,704

    )

     

     

    (26,501

    )

     

     

    (13,407

    )

    Provision for income taxes

     

     

    (222

    )

     

     

    (206

    )

     

     

    (195

    )

     

     

    (813

    )

     

     

    (1,017

    )

    Income from operations

     

     

    86,240

     

     

     

    92,816

     

     

     

    95,276

     

     

     

    357,708

     

     

     

    347,687

     

    Add:

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    28,226

     

     

     

    28,301

     

     

     

    29,392

     

     

     

    110,203

     

     

     

    121,074

     

    Other income, net

     

     

    1,272

     

     

     

    1,079

     

     

     

    883

     

     

     

    4,232

     

     

     

    1,566

     

    EBITDA

     

    $

    115,738

     

     

    $

    122,196

     

     

    $

    125,551

     

     

    $

    472,143

     

     

    $

    470,327

     

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240220363712/en/

    Get the next $WLKP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WLKP

    DatePrice TargetRatingAnalyst
    3/2/2022$30.00 → $31.00Buy
    Deutsche Bank
    7/16/2021$27.00Buy → Underperform
    BofA Securities
    More analyst ratings

    $WLKP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Gilson Jean-Marc bought $2,025 worth of Common Units (95 units at $21.25), increasing direct ownership by 0.81% to 11,803 units (SEC Form 4)

    4 - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/29/25 3:36:25 PM ET
    $WLKP
    Major Chemicals
    Industrials

    President and CEO Gilson Jean-Marc bought $163,637 worth of Common Units (7,461 units at $21.93), increasing direct ownership by 176% to 11,708 units (SEC Form 4)

    4 - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/28/25 8:33:56 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Amendment: President and CEO Gilson Jean-Marc bought $7,344 worth of Common Units (320 units at $22.95), increasing direct ownership by 10% to 3,427 units (SEC Form 4)

    4/A - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/28/25 8:33:42 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $WLKP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Westlake Chemical Partners LP Filed Annual Report

    Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on March 4, 2026. A copy of this 10-K may be found on the Partnership's website, www.wlkpartners.com, by selecting the "Investor Relations" tab, then "SEC Filings." Unitholders of the Partnership may receive a hard copy of its Annual Report on Form 10-K, including complete audited financial statements, free of charge. Requests should be submitted in writing to Westlake Chemical Partners LP – 2025 Form 10-K, 2801 Post Oak Blvd., Suite 600, Houston, TX 77056. About Westlake Chemical Part

    3/4/26 4:15:00 PM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2025 Results

    Strong fourth quarter coverage ratio of 1.13x following the completion of the Petro 1 turnaround Declared quarterly distribution of $0.4714 per unit; 46th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2025 of $14.5 million, or $0.41 per limited partner unit, which was relatively in line with fourth quarter 2024 net income of $15.0 million. Cash flows from operating activities in the fourth quarter of 2025 were $120.4 million, a decrease of $12.1 million compared to fourth quarter 2024 cash flows from operating activities of $132.5 million, due to lower

    2/24/26 6:30:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners Announce Fourth Quarter and Full Year Earnings for 2025 Conference Call

    Westlake Chemical Partners (NYSE:WLKP) will release its fourth quarter and full year 2025 earnings prior to the market opening on Tuesday, February 24, 2026. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI75a6b835bd404a6196626a29eaf3bd8f. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/

    2/10/26 9:00:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $WLKP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Deutsche Bank reiterated coverage on Westlake Chemical with a new price target

    Deutsche Bank reiterated coverage of Westlake Chemical with a rating of Buy and set a new price target of $31.00 from $30.00 previously

    3/2/22 9:14:17 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners downgraded by BofA Securities with a new price target

    BofA Securities downgraded Westlake Chemical Partners from Buy to Underperform and set a new price target of $27.00

    7/16/21 8:38:08 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical downgraded by UBS with a new price target

    UBS downgraded Westlake Chemical from Buy to Neutral and set a new price target of $25.00 from $23.00 previously

    3/18/21 7:11:14 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $WLKP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Gilson Jean-Marc bought $2,025 worth of Common Units (95 units at $21.25), increasing direct ownership by 0.81% to 11,803 units (SEC Form 4)

    4 - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/29/25 3:36:25 PM ET
    $WLKP
    Major Chemicals
    Industrials

    President and CEO Gilson Jean-Marc bought $163,637 worth of Common Units (7,461 units at $21.93), increasing direct ownership by 176% to 11,708 units (SEC Form 4)

    4 - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/28/25 8:33:56 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Amendment: President and CEO Gilson Jean-Marc bought $7,344 worth of Common Units (320 units at $22.95), increasing direct ownership by 10% to 3,427 units (SEC Form 4)

    4/A - Westlake Chemical Partners LP (0001604665) (Issuer)

    8/28/25 8:33:42 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $WLKP
    SEC Filings

    View All

    SEC Form S-3 filed by Westlake Chemical Partners LP

    S-3 - Westlake Chemical Partners LP (0001604665) (Filer)

    3/4/26 5:08:27 PM ET
    $WLKP
    Major Chemicals
    Industrials

    SEC Form 10-K filed by Westlake Chemical Partners LP

    10-K - Westlake Chemical Partners LP (0001604665) (Filer)

    3/4/26 1:01:38 PM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners LP filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Westlake Chemical Partners LP (0001604665) (Filer)

    2/24/26 7:22:35 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $WLKP
    Financials

    Live finance-specific insights

    View All

    Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2025 Results

    Strong fourth quarter coverage ratio of 1.13x following the completion of the Petro 1 turnaround Declared quarterly distribution of $0.4714 per unit; 46th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2025 of $14.5 million, or $0.41 per limited partner unit, which was relatively in line with fourth quarter 2024 net income of $15.0 million. Cash flows from operating activities in the fourth quarter of 2025 were $120.4 million, a decrease of $12.1 million compared to fourth quarter 2024 cash flows from operating activities of $132.5 million, due to lower

    2/24/26 6:30:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners Announce Fourth Quarter and Full Year Earnings for 2025 Conference Call

    Westlake Chemical Partners (NYSE:WLKP) will release its fourth quarter and full year 2025 earnings prior to the market opening on Tuesday, February 24, 2026. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register-conf.media-server.com/register/BI75a6b835bd404a6196626a29eaf3bd8f. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/

    2/10/26 9:00:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    Westlake Chemical Partners LP Announces Third Quarter 2025 Results

    Renewed Ethylene Sales Agreement through 2027 at existing terms Declared quarterly distribution of $0.4714 per unit; 45th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2025 of $14.7 million, or $0.42 per limited partner unit, which was below third quarter 2024 net income of $18.1 million. Cash flows from operating activities in the third quarter of 2025 were $105.2 million, a decrease of $20.9 million compared to third quarter 2024 cash flows from operating activities of $126.1 million. For the three months ended September 30, 2025, MLP distributable ca

    10/30/25 6:30:00 AM ET
    $WLKP
    Major Chemicals
    Industrials

    $WLKP
    Leadership Updates

    Live Leadership Updates

    View All

    Westlake Chemical Partners Appoints Lisa Friel to Board of Directors

    Westlake Chemical Partners (NYSE:WLKP) today announced that Ms. Lisa A. Friel has been appointed to the board of directors of its general partner, Westlake Chemical Partners GP LLC. She will replace Ms. Angela A. Minas, who previously informed the company that she would resign from the board effective upon the appointment of her successor. Ms. Friel was the Managing Partner of Ernst & Young LLP's San Antonio, Texas office from July 2012 until her retirement in September 2020. Ms. Friel began her career with Ernst & Young LLP in 1988. She is currently the Chair of the Board of Directors for the United Way of San Antonio. Ms. Friel holds a bachelor's of science degree in Accounting and Busi

    4/27/23 4:15:00 PM ET
    $WLKP
    Major Chemicals
    Industrials

    Woodside Energy Group Ltd Announces Changes to Woodside Board

    Retirement of Dr Sarah Ryan and Dr Christopher Haynes from the Woodside BoardPERTH, AUSTRALIA / ACCESSWIRE / March 8, 2023 / The Board of Woodside announces the retirement of Dr Sarah Ryan and Dr Christopher Haynes as Directors of Woodside. Dr Ryan and Dr Haynes will be standing down from their respective offices with effect from the conclusion of Woodside's 2023 Annual General Meeting, scheduled to be held on 28 April 2023 (2023 AGM).Dr Haynes has served on Woodside's Board since 2011 and is a member of the Audit & Risk Committee, the Sustainability Committee and the Nominations & Governance Committee.Dr Ryan joined the Woodside Board in December 2012 and serves on the Audit & Risk Committe

    3/8/23 2:20:00 AM ET
    $CEQP
    $WDS
    $WLKP
    Oil & Gas Production
    Utilities
    Energy
    Major Chemicals

    Crestwood Appoints Two New Independent Directors Solidifying its Leading MLP Corporate Governance Model

    Crestwood Equity Partners LP (NYSE:CEQP) ("Crestwood") announced today that Angela A. Minas and Clay C. Williams have been appointed to serve on the Board of Directors of its general partner effective January 1, 2022. "I am pleased to welcome Angela and Clay to the Crestwood Board of Directors. Both of these highly regarded individuals bring a wealth of U.S. and global industry experience and perspective to our boardroom that will greatly benefit Crestwood as we navigate the dynamic energy industry and take advantage of opportunities to continue building a leading midstream infrastructure company," said Robert G. Phillips, Chairman, President and Chief Executive Officer of Crestwood's gene

    11/11/21 1:00:00 PM ET
    $BHE
    $CEQP
    $CINR
    Electrical Products
    Technology
    Oil & Gas Production
    Utilities

    $WLKP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Westlake Chemical Partners LP (Amendment)

    SC 13D/A - Westlake Chemical Partners LP (0001604665) (Subject)

    2/14/24 4:19:23 PM ET
    $WLKP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Westlake Chemical Partners LP (Amendment)

    SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)

    2/14/24 2:02:09 PM ET
    $WLKP
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Westlake Chemical Partners LP (Amendment)

    SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)

    2/12/24 4:43:59 PM ET
    $WLKP
    Major Chemicals
    Industrials